A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether external support devices reduce sternal wound complications after cardiac surgery with sternotomy. Altogether 116 papers were found using the reported search, of which six presented the best evidence to answer the clinical question. The author, year, journal, study type, patient group studied, relevant outcomes, results and study weaknesses are tabulated. Six randomized controlled trials investigating the effect of external chest support devices on sternal wound complications in adult patients undergoing sternotomy for cardiac surgery were selected. These studies demonstrate a significant reduction of deep sternal wound complication on comparing external support with no support. Non-elastic devices were more effective in reducing sternal complication compared with the elastic bandage (four trials). Three studies reported significant reduction of mean hospital stay in patients receiving non-elastic chest support devices. We conclude that early poststernotomy use of an external non-elastic sternal support device reduces overall sternal wound complications and may reduce the hospital length of stay.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This protocol is fully described in the ICVTS [1] .
CLINICAL SCENARIO
During the morning HDU round, the consultant surgeon suggests using an external thoracic support device on a male patient with moderate chronic obstructive pulmonary disease (COPD) who underwent a triple vessel coronary artery bypass surgery yesterday. The nurse accompanying you promptly applies the device but on the following day, you find the patient not wearing the device. On direct questioning, the patient says that the device is uncomfortable and would wear it only if there was sufficient evidence to support reduced sternal wound complication with its use. Therefore, you resolve to search the literature to find the evidence. 
THREE-PART QUESTION

Study 2
Robiscek closure for all patients Gorlitzer et al. [2] evaluated sternal wound complications in adult patients following cardiac surgery by randomizing 455 patients postoperatively to receive Posthorax external support or no support. In this study, 23.2% patients who were randomized to the external support group refused to wear the Posthorax vest due to the close fit and slipping of the vest. These patients were analysed as a separate third group. The patients were followed up for 90 days and the authors report a reduction in overall sternal wound complications (0.6 vs 4.9%; P = 0.015) in the vest group. A higher prevalence of diabetes was observed in the Posthorax vest and the refused vest groups compared with the non-vest group. A higher incidence of sternal wound complications (9.4%) was also observed in the refused vest group; however, the incidence of perfusion time exceeding 200 min was higher in this group compared with other groups.
Celik et al. [3] reported two studies in their paper. The first study was a retrospective cohort analysis of 842 patients who underwent elective cardiac surgery. The patients were stratified into two groups based on the presence or absence of COPD. Although the technique of sternal closure was similar in all patients, their analysis demonstrated that patients with COPD had higher incidence of sternal dehiscence and deep sternal wound complications (7.9 vs 1.2%, P < 0.001). The second study was an RCT with 221 adult patients with COPD who underwent cardiac surgery and were randomized to Posthorax vest postoperatively (n = 100) or no vest (n = 121). All patients were closed using the Robiscek lateral reinforced sternal closure and were followed up for 6 months postoperatively. They found a significant reduction of overall sternal wound complication (1 vs 11.5%, P = 0.002) and deep sternal wound complication (1 vs 9%, P = 0.02) in the Posthorax vest group. They analysed and concluded that 15 patients with moderate to severe COPD need to be treated to prevent one sternal wound complication (number needed to treat, NNT = 15).
Naismith and Street [4] performed an RCT involving 20 female patients with bra cup size greater than or equal to C cup and randomly allocated them into Cardibra (n = 10) or regular bra (n = 10) after cardiac surgery. The aim was to evaluate the effectiveness of Cardibra on sternal wound healing and postoperative pain.
Wound was assessed on 7th, 14th and 42nd day using the Flanagan's wound assessment practical framework by measuring in millimetres, the length of non-approximated wound edges and the area of redness and swelling of the skin around the sternotomy wound. A Likert scale was used for pain scoring on the 1st, 3rd, 5th, 7th, 14th and 42nd day after surgery. They found no significant difference in pain relief or sternal wound complication between groups. However, the sample size in this study was extremely small.
Gorlitzer et al. [5] studied the effectiveness of Posthorax vest and the elastic bandage in reducing reoperations due to sternal wound complications. Patients who failed to use the vest were excluded (27.9%) from the final analyses. They observed that the reoperation rates due to sternal wound complications during the 90-day follow-up period were 0.6% in the Posthorax vest group and 3.9% in the elastic bandage group (P = 0.05). Total length of hospital stay was also shorter in the Posthorax vest group. They concluded that the need for additional surgical procedures was significantly reduced using the support vest. Unfortunately, some of the patients initially randomized were excluded from the final analysis, but it would have been interesting if this paper had published an analysis on 'intention to treat' basis as well.
Tewarie et al. [6] performed an RCT to determine the effect of Stern-E-Fix corset on prevention of sternal wound complications and mediastinitis in patients after cardiac surgery with sternotomy. They randomized 750 male patients to immediately receive either the Stern-E-Fix corset (n = 380) or an elastic bandage (n = 370) postoperatively. Patients received support devices for 6 weeks, given from first postoperative day, the mean follow-up was 8 weeks and 96% patients were pleased with the design. The sternal closure and antibiotic protocol were similar in all patients and female patients were not included in this study. They observed that only 1 patient in the corset group developed sternal complication requiring a reoperation as opposed to 22 patients in the elastic bandage group. They also found significant reduction in the mean length of hospital stay in the corset group (12.5 vs 18 days; P = 0.002). It is important to appreciate that the mean ventilation time was significantly higher in the elastic bandage group (2.5 vs 1.28 days, P = 0.01) which may have influenced the results.
Gorlitzer et al. [7] reported on a multicentre RCT with 2539 patients assessing the efficacy of Posthorax vest in comparison to elastic bandage in preventing sternal wound complications after cardiac surgery. The Posthorax vest was assigned to 1351 patients Exclusion criteria: <20 years old congenital heart defects or mechanical reanimation or irradiation or transplantation and the elastic bandage to 1176 patients. The Posthorax vest was refused by 17.8% patients after randomization. The patients were followed up for 90 days, and the outcomes were analysed on intention-to-treat basis. They found significant decrease in deep sternal wound complication in the patients randomized to Posthorax group (1.04 vs 2.27%; P = 0.017). All complications in the vest group occurred among patients who did not receive or refused the vest. In these studies, the Stern-E-Fix corset was not evaluated in female patients and a substantial population found the Posthorax vest uncomfortable and therefore refused to wear it.
CLINICAL BOTTOM LINE
Early post-sternotomy use of the available external non-elastic sternal support devices reduces sternal wound complications and may be associated with a shorter length of hospital stay.
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